Modalis Therapeutics Corp Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Modalis Therapeutics Corp - Alpha Spread

Modalis Therapeutics Corp
TSE:4883

Watchlist Manager
Modalis Therapeutics Corp Logo
Modalis Therapeutics Corp
TSE:4883
Watchlist
Price: 101 JPY -6.48% Market Closed
Market Cap: 4.3B JPY
Have any thoughts about
Modalis Therapeutics Corp?
Write Note

Wall Street
Price Targets

Price Targets Summary
Modalis Therapeutics Corp

There are no price targets for Modalis Therapeutics Corp.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Modalis Therapeutics Corp Competitors:
Price Targets
IGMS
IGM Biosciences Inc
36% Upside
1801
Innovent Biologics Inc
32% Upside
068270
Celltrion Inc
29% Upside
INIT
Initiator Pharma A/S
233% Upside
ALERS
Eurobio Scientific SA
23% Upside
REGN
Regeneron Pharmaceuticals Inc
5% Upside
TRDA
Entrada Therapeutics Inc
46% Upside
688428
InnoCare Pharma Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Modalis Therapeutics Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-95%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Modalis Therapeutics Corp

Operating Income forecast
is not available for
Modalis Therapeutics Corp

Net Income
Forecast

Net Income Estimate
Modalis Therapeutics Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
15%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Modalis Therapeutics Corp's stock price target?
Not Available

Modalis Therapeutics Corp doesn't have any price targets made by Wall Street professionals.

Back to Top